Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs
The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.
from NYT > Health https://ift.tt/1ViXPCn
via IFTTT
from NYT > Health https://ift.tt/1ViXPCn
via IFTTT

No comments